Intelligence · Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
Tiragolumab, CISPLATIN , Tecentriq 1 200 mg concentrate for solution for infusion, GEMCITABINE
Hoffmann-La Roche
Urothelial carcinoma (UC)
1 trial -
Tirzepatide
Eli Lilly and Company
Healthy
1 trial -
Tissue Plasminogen Activator (tPA)
Hospital Authority, Hong Kong
Peritoneal Dialysis
1 trial -
To assess the relative BA of a low-strength FDC tablet formulation of niraparib plus AA compared to niraparib and AA co-administered as single agents after single dose administration and to assess BE of a regular strength FDC tablet formulation of niraparib plus AA compared to niraparib and AA co-administered as single agents at steady state in men with prostate cancer
Janssen-Cilag International N.V.
Metastatic castration-resistant prostate cancer (mCRPC)
1 trial -
To evaluate the pharmacokinetics and safety of nolasiban
Novo Nordisk A/S
not applicable (submitted trial is a pharmacokinetic study in healthy subjects)
1 trial -
Tofacitinib tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Amyotrophic Lateral Sclerosis
1 trial -
Tolvaptan 15mg or 30mg or 60mg or Placebo
Otsuka Beijing Research Institute
Healthy
1 trial -
Topiramate 2 x 25 mg tablet
Teva Pharma GmbH
Healthy
1 trial -
Topiramate 25 mg Capsules
Teva Pharma GmbH
Healthy
1 trial -
Topiramate Capsules, 25 mg
Teva Pharma GmbH
Healthy
2 trials -
Topiramate IR
SUPERNUS PHARMACEUTICALS, INC.
Epilepsy
1 trial -
Topiramate Tablets
Teva Pharma GmbH
Healthy
1 trial -
Training with 4D Motion Capture Device
4D Molecular Therapeutics
Stroke
1 trial -
Trandolapril 4 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Tranexamic Acid;
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iatrogenic Endobronchial Bleeding
1 trial -
Tranilast
The First People's Hospital of Lianyungang
Mucinoses
1 trial -
TransCon PEG treprostinil
United Therapeutics Europe Ltd
PAH
1 trial -
Transdermal Nicotine Patch
BRIGHT MINDS BIOSCIENCES INC.
E-cigarette Use
1 trial -
Trastuzumab
Hoffmann-La Roche
Early Breast Cancer
1 trial -
Trastuzumab Deruxtecan
Daiichi Sankyo
Recurrent or Metastatic Solid Tumors
1 trial -
Trastuzumab Deruxtecan, and pembrolizumab in participants with Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
Daiichi Sankyo
Locally advanced/metastatic breast or non-small cell lung cancer
1 trial -
Treatment A
Tonix Pharmaceuticals Holding
Healthy Adults
1 trial -
Treatment A
Pfizer
Asthma
1 trial -
Treatment A
Pfizer
Healthy
1 trial -
Treatment A
Tonix Pharmaceuticals Holding
Healthy
1 trial -
Treatment A (rosuvastatin)
LEXICON PHARMACEUTICALS, INC.
Healthy
1 trial -
Treatment A digoxin
LEXICON PHARMACEUTICALS, INC.
Healthy
1 trial -
Treatment A-Bemnifosbuvir/Ruzasvir FDC administered fasting
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Treatment A: Fp MDPI
Teva Pharma GmbH
Asthma
1 trial -
Treatment as usual (TAU)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
1 trial -
Treatment of Respiratory Complications Associated with COVID-19, Influenza A, Metapneumovirus, Respiratory Syncytial Virus (RSV) Infection Using Wharton’s Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans®): open Phase IB Clinical Trial
Lacuna Pharma Pty Ltd
Respiratory viral disease, COVID-19, Influenza A, Metapneumovirus, Respiratory syncytial virus Infection
1 trial -
Treatment of advanced or metastatic triple negative breast cancer with tumor infiltrating lymphocytes (TILs).
The George Institute
advanced or metastasic triple-negative breast cancer
1 trial -
Treatment of cancer with Immune Checkpoint Inhibition therapy boosted by High Intensity Focused Ultrasound Histotripsy (the iFOCUS study)
Disc Medicine
Metastatic or unresectable solid malignancies. Standard of care treatment options must not be available or not be considered feasible. Patients must have a primary tumor or metastasis that is suitable for HIFU-HT treatment.
1 trial -
Treatment sequence AB
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
Trebananib 3 mg/kg
Takeda
Neoplasms, Advanced Solid
1 trial -
Treprostinil Inhalation Powder
United Therapeutics Europe Ltd
Pulmonary Arterial Hypertension
1 trial -
Treprostinil diethanolamine
United Therapeutics Europe Ltd
Hypertension, Pulmonary
2 trials -
Trial of the novel peroral anti-tumor treatment in patients with solid tumors
Lacuna Pharma Pty Ltd
Metastatic or locally advanced solid tumors for which no standard therapy exists or standard therapy has failed: tumors of lung, head and neck, colon, stomach, esophagus, breast, ovary and/or fallopian tube or primary peritoneal high-grade serous carcinoma
1 trial -
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors
Genmab A/S
Advanced Malignant Solid Tumors
1 trial -
Trial to assess the safety and antitumor activity of GEN1057 on malignant solid tumors
Genmab A/S
Metastatic or advanced malignant solid tumors
1 trial -
Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants
Lacuna Pharma Pty Ltd
Clostridioides difficile (C. difficile)
1 trial -
Triamcinolone Acetonide Extended-Release Injectable Suspension
Pacira Ireland Limited
Osteoarthritis, Knee
1 trial -
Trichostatin A
Vanda Pharmaceuticals Netherlands B.V.
Relapsed or Refractory Hematologic Malignancies
1 trial -
Triheptanoin
Ultragenyx UK Limited
Pyruvate Dehydrogenase Complex Deficiency
1 trial -
Triheptanoin
Ultragenyx UK Limited
Glycogen Storage Disease Type I
1 trial -
Triprorelin for injection
The First People's Hospital of Lianyungang
Prostate Cancer (CRPC)
1 trial -
Tuberculosis (TB) vaccine (Ad5-105K)
CanSino Biologics
Tuberculosis
1 trial -
Tuberculosis Vaccine
Biotech Pharmaceutical Co.,
Tuberculosis
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs